Extravasating Neutrophils Open Vascular Barrier and Improve Liposomes Delivery to Tumors
Liposomes are the most extensively used nanocarriers in cancer therapy. Despite the advantages these vehicles provide over free drugs, there are still limitations with regards to the efficiency of liposomes delivery to tumors and off-target accumulation. A better understanding of nanodrugs extravasa...
Saved in:
Published in | ACS nano Vol. 13; no. 11; pp. 12599 - 12612 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
26.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!